What Should Patients with Drug-Induced Liver Injury Eat?

The liver is large in size and fragile in texture; thus, it is highly susceptible to injury upon exposure to blunt or penetrating trauma. Such injury may lead to intra-abdominal hemorrhage or bile leakage, resulting in hemorrhagic shock or biliary peritonitis—conditions with potentially severe consequences that necessitate prompt diagnosis and appropriate management. So, what should patients with drug-induced liver injury (DILI) eat? Let’s explore this further.

What Should Patients with Drug-Induced Liver Injury Eat?

Drug-induced liver injury is primarily managed pharmacologically. Commonly used medications include polyenylphosphatidylcholine, reduced glutathione, compound glycyrrhizin, magnesium isoglycyrrhizinate, and diammonium glycyrrhizinate. If total bilirubin levels are elevated, additional agents for cholestasis management—such as ursodeoxycholic acid or ademetionine (S-adenosyl-L-methionine disodium 2,3-butanedisulfonate)—may be indicated.

However, caution is essential: in severe cases, oral medication alone is insufficient. Intravenous drug therapy should be initiated promptly, and supportive measures—including nutritional support and symptomatic treatment—may be required. In select cases, artificial liver support with plasma exchange may be necessary.

Dietary management for drug-induced liver injury generally emphasizes light, easily digestible foods with minimal gas production. Patients should avoid spicy, irritating, or “heat-inducing” foods. A balanced intake of carbohydrates, high-quality proteins, and abundant vitamins is recommended.

What Are the Symptoms of Liver Injury?

Typically, patients with traumatic liver injury have a clear history of right thoracoabdominal trauma and present with symptoms such as thirst, nausea, and vomiting. Clinical manifestations are predominantly those of hypovolemic shock and peritonitis. In some cases of severe hepatic trauma, massive intra-abdominal hemorrhage may occur, leading to abdominal distension. Subcapsular or intraparenchymal hepatic hematomas often manifest clinically as dull pain in the right upper quadrant; physical examination may reveal hepatomegaly or an upper abdominal mass. If the hematoma communicates with the biliary tract, biliary hemorrhage may ensue, causing upper gastrointestinal bleeding; recurrent episodes can result in chronic progressive anemia. When ongoing hemorrhage within the hematoma increases intrahepatic pressure excessively, the Glisson capsule may rupture suddenly under external stress, precipitating acute hemorrhagic shock. Therefore, in non-surgical management of subcapsular hematomas, clinicians must remain vigilant for the possibility of delayed hemorrhage.

We hope the above information is helpful to you.